Hyperhomohomocysteinemia as a risk factor of cardiovascular pathology in patients with chronic kidney disease. Modern view of the problem

Postovitenko, K. P.; Iliuk, I. A.; Baranova, I. V.

Домівка
→
Кафедра фізичної та реабілітаційної медицини
→
Наукові публікації каф. медичної реабілітації
→
Перегляд матеріалів

dc.contributor.author	Postovitenko, K. P.	en
dc.contributor.author	Iliuk, I. A.	en
dc.contributor.author	Baranova, I. V.	en
dc.date.accessioned	2025-03-07T13:29:13Z
dc.date.available	2025-03-07T13:29:13Z
dc.date.issued	2024
dc.identifier.citation	Hyperhomohomocysteinemia as a risk factor of cardiovascular pathology in patients with chronic kidney disease. Modern view of the problem / K. P. Postovitenko, I. A. Iliuk, I. V. Baranova // The greatest humankind achievements in healthcare and veterinary medicine : International scientific conference, February 7–8, 2024, Riga. – Riga (Latvia), 2024. – P. 32–35.	en
dc.identifier.other	DOI: https://doi.org/10.30525/978-9934-26-401-6-8	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/7099	en
dc.description.abstract	Chronic kidney disease (CKD) is a significant problem today. The presence of renal dysfunction is a powerful, independent risk factor for the development of cardiovascular complications. About 60% of patients with end-stage renal failure die within a year from acute myocardial infarction, and the risk of further cardiovascular complications is directly proportional to the progression of renal dysfunction. One of the "unconventional" risk factors for the accelerated development of cardiovascular pathology in severe stages of CKD is hyperhomocysteinemia (HНC).	en
dc.language.iso	en	en
dc.publisher	Baltija Publishing	en
dc.subject	chronic kidney disease	en
dc.subject	cardiovascular complications	en
dc.subject	acute myocardial infarction	en
dc.subject	hyperhomocysteinemia	en
dc.title	Hyperhomohomocysteinemia as a risk factor of cardiovascular pathology in patients with chronic kidney disease. Modern view of the problem	en
dc.type	Article	en